Medicine guide
Akeega
·
- Prescription status not stated
- Cancer treatments and immune-system medicines
- Active substance
- Niraparib;abiraterone acetate
- Made by
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Treatment of adult patients with prostate cancer.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | |
|---|---|
| Active substance | Niraparib;abiraterone acetate |
| Used in | Cancer treatments and immune-system medicines |
| Classification | L01 · Cancer treatments and immune-system medicines |
| Authorised on | 2023-04-19 |
| Last updated by the regulator | 2026-08-18 |
| EMA product number | EMEA/H/C/005932 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).